Showing 1 to 10 of 11 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
A Large-scale Longitudinal Oncology Platform: Personalize my Treatment
PMT Exactis NCT02355171  Temporary interruption
|
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DU SAINT-SACREMENT
|
Other |
Dr. Louise Provencher Éric Vachon 418-682-7511 poste 84728 |
|
Partnership initiative for the Evaluation of technological innovation in Radiotherapy (PERA)
PERA NCT03378856  Recruiting
|
CISSS DE LAVAL
HOPITAL DE LA CITE-DE-LA-SANTE
|
Other |
Dr. Marie-Andrée Fortin Solange Tremblay 450-668-1010 poste 23603 |
|
Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy
PERA NCT03378856 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Other |
Dr. Éric Vigneault Josée Allard 418-525-4444 poste 16730 |
|
A Phase 1b/2a Two-Part, Open-Label, Multicenter Study to Evaluate the Safety and Pharmacokinetics of OC-001 as Monotherapy and in Combination With an Anti-PD-1/Anti-PD-L1 Antibody in Patients With Selected Locally Advanced or Metastatic Cancers
OCEL-01 NCT04260802 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Other |
Dr. Wilson Miller Ivgenya Kosenko 514-340-8222 poste 25981 |
|
Partnership Initiative for the Evaluation of Technological Innovation in Radiotherapy
PERA NCT03378856 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Other |
Dr. Cynthia Ménard Diane Trudel 514-890-8000 poste 11181 |
|
A Phase 1b/2a Two-Part, Open-Label, Multicenter Study to Evaluate the Safety and Pharmacokinetics of OC-001 as Monotherapy and in Combination With an Anti-PD-1/Anti-PD-L1 Antibody in Patients With Selected Locally Advanced or Metastatic Cancers
OCEL-01 NCT04260802 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Other |
Dr. Diane Provencher Adeline Hamon 514-890-8000 poste 30737 |
|
Lung biobank
Biobanque du poumon Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Other |
Dr. Bertrand Routy Julie Malo 514-890-8000 poste 23848 |
|
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
CARMA-BROS NCT04151342 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Other |
Dr. Normand Blais Wiam Belkaid 514-890-8000 |
|
Long Term Follow-Up of Participants Exposed to GSK3377794 (NY-ESO-1c259 T), a Genetically Engineered NY-ESO-1 Specific T Cell Receptor
GSK 208750 NCT03391778 Recruiting
|
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
|
Other |
Dr. Jonathan Noujaim Olivier Cormier 514-252-3400 poste 5966 |
|
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
CARMA-BROS NCT04151342 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Other |
Dr. Nicole Bouchard Anick Champoux 819-346-1110 poste 12811 |
Groupe d'étude en oncologie du Québec